On 9/5/25, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock enjoyed a major increase of 17.9%, closing at $14.01. Moreover, exceptionally high trading volume at 267% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 18.3% during the last week.
Current PriceTarget Research Rating
EyePoint Pharmaceuticals has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. EyePoint Pharmaceuticals has a poor Appreciation Score of 21 but a good Power Rating of 84, producing the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment